GS

Gagnon Securities Portfolio holdings

AUM $519M Turnover 11.24%
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$360M
AUM Growth
+$129M
Cap. Flow
-$10.2M
Cap. Flow %
-2.84%
Top 10 Hldgs %
65.88%
Holding
103
New
8
Increased
23
Reduced
41
Closed
14
Avg Time Held
2.3 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
GFN
General Finance Corporation
GFN
+$10.6M
2
INST icon
Instructure, Inc.
INST
+$4.26M
3
WPX
WPX Energy, Inc.
WPX
+$2.95M
4
AMBR icon
Amber Road Inc
AMBR
+$1.46M
5
PSIX icon
Power Solutions International
PSIX
+$1.24M

Top Sells

Rank Stock Value
1
GFNSL
General Finance Corporation Senior Notes due 2021
GFNSL
+$10.9M
2
ATHN
Athenahealth, Inc.
ATHN
+$4.4M
3
XTLY
Xactly Corporation
XTLY
+$3.89M
4
LL icon
LL Flooring Holdings, Inc.
LL
+$2.72M
5
WWE
World Wrestling Entertainment
WWE
+$1.38M

Sector Composition

Rank Sector Weight
1 Communication Services 38.9%
2 Technology 23.84%
3 Industrials 14.25%
4 Consumer Discretionary 6.18%
5 Energy 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SYF icon
51
Synchrony
SYF
$23.2B
$423K 0.12%
14,182
-81
-0.6% -$2.4K
2015 Q4
6 quarters
JNJ icon
52
Johnson & Johnson
JNJ
$611B
$387K 0.11%
2,924
– –
2013 Q4
14 quarters
SRGA
53
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$385K 0.11%
2,192
-6,675
-75% -$949K
2013 Q2
16 quarters
WRK icon
54
DELISTED
WestRock Company
WRK
$365K 0.1%
6,441
– –
2016 Q1
5 quarters
DHI icon
55
D.R. Horton
DHI
$37.2B
$340K 0.09%
9,839
– –
2014 Q2
12 quarters
CLAR icon
56
Clarus
CLAR
$132M
$333K 0.09%
50,368
-24,725
-33% -$145K
2015 Q1
9 quarters
IPHI
57
DELISTED
INPHI CORPORATION
IPHI
$324K 0.09%
9,437
+836
+10% +$33.6K
2013 Q2
16 quarters
URA icon
58
Global X Uranium ETF
URA
$4.99B
$320K 0.09%
24,316
– –
2016 Q4
2 quarters
PFE icon
59
Pfizer
PFE
$167B
$306K 0.08%
9,605
– –
2016 Q1
5 quarters
VNDA icon
60
Vanda Pharmaceuticals
VNDA
$255M
$296K 0.08%
18,131
-60
-0.3% -$865
2013 Q2
16 quarters
LEN icon
61
Lennar Class A
LEN
$17.4B
$292K 0.08%
5,746
– –
2016 Q3
3 quarters
SONC
62
DELISTED
Sonic Corp
SONC
$276K 0.08%
10,424
– –
2016 Q4
2 quarters
EOG icon
63
EOG Resources
EOG
$80.9B
$273K 0.08%
3,018
+8
+0.3% +$737
2016 Q2
4 quarters
CELG
64
DELISTED
Celgene Corp
CELG
$256K 0.07%
1,968
-4
-0.2% -$490
2016 Q3
3 quarters
PBI icon
65
Pitney Bowes
PBI
$2.27B
$222K 0.06%
+14,731
New +$215K
2017 Q2
0 quarters
BELFB icon
66
Bel Fuse Inc Class B
BELFB
$3.23B
$218K 0.06%
8,811
– –
2013 Q3
15 quarters
CBK icon
67
DELISTED
Christopher & Banks Corporation
CBK
$218K 0.06%
166,739
-644,821
-79% -$820K
2013 Q2
16 quarters
URG icon
68
Ur-Energy
URG
$324M
$215K 0.06%
343,084
– –
2014 Q1
13 quarters
CCJ icon
69
Cameco
CCJ
$35.5B
$193K 0.05%
21,195
– –
2016 Q3
3 quarters
DNN icon
70
Denison Mines
DNN
$1.97B
$166K 0.05%
+377,302
New +$192K
2017 Q2
0 quarters
LPSN icon
71
DELISTED
LivePerson
LPSN
$143K 0.04%
869
-117
-12% -$16.1K
2013 Q2
16 quarters
AT icon
72
DELISTED
Atlantic Power Corporation
AT
$131K 0.04%
54,742
-78,800
-59% -$196K
2014 Q3
11 quarters
TTNP icon
73
DELISTED
Titan Pharmaceuticals
TTNP
$67K 0.02%
+10
New +$93K
2017 Q2
0 quarters
FLNA icon
74
Filana Therapeutics
FLNA
$34.8M
$65K 0.02%
15,568
+8,813
+130% +$41.6K
2013 Q3
15 quarters
SRNE
75
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$63K 0.02%
31,586
+20,470
+184% +$39.9K
2015 Q2
8 quarters
1 2
3
4

Similar funds

WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
MWC
MBM Wealth Consultants Chesterfield, Missouri $519M AUM 16.88% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $518M AUM 22.62% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return

Gagnon Securities's Q2 2017 Portfolio in Review

As of Q2 2017, Gagnon Securities held 103 positions worth $360M, up 56% from $231M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Gagnon Securities's Q2 2017 filing shows 8 new, 23 increased, 41 reduced and 14 closed positions. Its largest new stake was General Finance Corporation: 2,114,878 shares worth $10.9M. The largest sale was General Finance Corporation Senior Notes due 2021, an estimated $10.9M.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, up from 6.2% a quarter earlier, followed by Technology and Industrials.

  • Gagnon Securities's largest Q2 2017 buy was General Finance Corporation: 2,114,878 shares worth $10.9M.
  • Gagnon Securities added most to Instructure, Inc. in Q2 2017, an estimated $4.26M increase.
  • Gagnon Securities's biggest Q2 2017 reduction was Athenahealth, Inc., cutting an estimated $4.4M.
  • Gagnon Securities fully exited General Finance Corporation Senior Notes due 2021 in Q2 2017, selling an estimated $10.9M.
  • Gagnon Securities's ten largest holdings make up 66% of its $360M portfolio in Q2 2017.
  • Gagnon Securities opened 8 new positions and closed 14 in Q2 2017.
  • Gagnon Securities's portfolio value rose 56% quarter-over-quarter to $360M.

Based on Gagnon Securities's 13F filing for Q2 2017, filed 20 Jul 2017.